Cite
Investigation of Molecular Weight, Polymer Concentration and Process Parameters Factors on the Sustained Release of the Anti-Multiple-Sclerosis Agent Teriflunomide from Poly( ε -caprolactone) Electrospun Nanofibrous Matrices.
MLA
Bikiaris, Nikolaos D., et al. “Investigation of Molecular Weight, Polymer Concentration and Process Parameters Factors on the Sustained Release of the Anti-Multiple-Sclerosis Agent Teriflunomide from Poly( ε -Caprolactone) Electrospun Nanofibrous Matrices.” Pharmaceutics, vol. 14, no. 8, Aug. 2022. EBSCOhost, https://doi.org/10.3390/pharmaceutics14081693.
APA
Bikiaris, N. D., Koumentakou, I., Michailidou, G., Kostoglou, M., Vlachou, M., Barmpalexis, P., Karavas, E., & Papageorgiou, G. Z. (2022). Investigation of Molecular Weight, Polymer Concentration and Process Parameters Factors on the Sustained Release of the Anti-Multiple-Sclerosis Agent Teriflunomide from Poly( ε -caprolactone) Electrospun Nanofibrous Matrices. Pharmaceutics, 14(8). https://doi.org/10.3390/pharmaceutics14081693
Chicago
Bikiaris, Nikolaos D, Ioanna Koumentakou, Georgia Michailidou, Margaritis Kostoglou, Marilena Vlachou, Panagiotis Barmpalexis, Evangelos Karavas, and George Z Papageorgiou. 2022. “Investigation of Molecular Weight, Polymer Concentration and Process Parameters Factors on the Sustained Release of the Anti-Multiple-Sclerosis Agent Teriflunomide from Poly( ε -Caprolactone) Electrospun Nanofibrous Matrices.” Pharmaceutics 14 (8). doi:10.3390/pharmaceutics14081693.